pediatric emergency medicine

Most Missed Question in Peds EM Exam Prep –  Cellulitis Antibiotics

POCUS cobblestoning = nonpurulent cellulitis. Learn why beta-lactams beat TMP-SMX/doxycycline and when to add MRSA coverage.

Subscribe

Subscribe

For mild, nonpurulent cellulitis without abscess or MRSA risk factors, choose a narrow oral beta-lactam targeting streptococci; among these options, penicillin is best.

 

Question – Antibiotic choice  

A 6 yo girl is brought to the ED because of a rash on her forearm. She is previously healthy and there is no history of skin and soft tissue infections in her immediate family. On exam, she is afebrile, non-toxic, and has no clinical abnormalities other than a 3 cm area of warmth, erythema, and tenderness on the volar aspect of her left forearm with some mild shotty axillary lymphadenopathy. A bedside ultrasound is performed and demonstrates increased echogenicity of the subcutaneous tissues with hyperechoic fat lobules separated by hypoechoic fluid-filled areas as seen in the image.

Image courtesy of Indi Trehan, MD 

Which of the following would be the most appropriate antibiotic to prescribe for this patient? 

Answer Options:

A. Clindamycin
B. Doxycycline
C. Penicillin
D. Trimethoprim/sulfamethoxazole 

 

Examinees often miss this because they over-treat all cellulitis as “MRSA until proven otherwise,” especially when ultrasound is used; however, the ultrasound finding here (“cobblestoning”) supports cellulitis without abscess, where streptococci predominate and MRSA-directed therapy is not routinely indicated.

While many current pathways and board-prep algorithms commonly prefer cephalexin (or amoxicillin/clavulanate depending on scenario) for outpatient nonpurulent cellulitis because it covers streptococci and MSSA, those are not listed. Per IDSA SSTI guidance (2014, still exam-relevant), mild nonpurulent cellulitis should receive an agent active against streptococci; penicillin is an acceptable narrow option for streptococcal disease and is the best choice among the answer set. AAP Red Book similarly emphasizes beta-lactams for streptococcal cellulitis/erysipelas, reserving MRSA-active agents for purulence, abscess, or MRSA risk factors.

 

Why This Pediatric Emergency Medicine Question Is Often Missed

  • “Cobblestoning” on POCUS confirms cellulitis but does not imply abscess or MRSA.
  • Test-takers conflate purulent SSTI algorithms (MRSA coverage) with nonpurulent cellulitis algorithms (streptococcal coverage).
  • Doxycycline and TMP-SMX have unreliable streptococcal coverage—an easy board trap.

 

What the Distractors Indicate

Option What It Tests / Implies Why It’s Wrong Here
Clindamycin MRSA coverage (and some GAS coverage) Not needed in low-risk, nonpurulent cellulitis; avoid broader MRSA-directed therapy when not indicated (IDSA 2014).
Doxycycline Community-acquired MRSA coverage Poor/unreliable Group A Strep coverage; also generally avoided in young children in many exam settings (though acceptable ≥8 years). Not appropriate here.
Penicillin Narrow streptococcal coverage Best match for uncomplicated nonpurulent cellulitis presumed due to streptococci; best among listed options.
Trimethoprim/sulfamethoxazole MRSA coverage Unreliable streptococcal coverage; inappropriate for nonpurulent cellulitis when streptococci are primary pathogens (IDSA 2014).

 

High-Yield Pearl for Exam Prep

Nonpurulent cellulitis + no abscess on ultrasound + no MRSA risks → treat streptococci with an oral beta-lactam, not TMP-SMX or doxycycline.

 

Core Learning Objectives

  1. Distinguish management of nonpurulent cellulitis from purulent SSTI/abscess in pediatric ED antibiotic selection.
  2. Identify antibiotic classes with unreliable Group A Streptococcus coverage that should be avoided for uncomplicated nonpurulent cellulitis.

 

The Exam “Test Trick” at Play

The vignette gives you POCUS findings (cobblestoning) to tempt you into “more aggressive” MRSA therapy. Boards want you to notice the *absence* of a drainable collection and the low-risk host—then select streptococcal-directed therapy rather than defaulting to MRSA agents with weak GAS activity. 

 

 

Additional Peds EM Practice Questions and Remediation for Cellulitis (Nonpurulent vs Purulent) 

Pediatric Emergency Medicine Practice Question 1 — Nonpurulent lower-leg cellulitis 

A 9-year-old with 2 days of expanding erythema and warmth on the calf, no fluctuance, afebrile, normal vitals, no MRSA history. Best oral outpatient antibiotic?

  • A. Trimethoprim/sulfamethoxazole
  • B. Cephalexin
  • C. Doxycycline
  • D. Linezolid
  • E. Ciprofloxacin

Answer and Remediation

A — Review: MRSA-focused; unreliable GAS coverage for nonpurulent cellulitis.

B — Correct response!: First-line for mild nonpurulent cellulitis in many pediatric pathways; covers streptococci and MSSA (IDSA 2014 framework; AAP Red Book principles).

C — Review: Unreliable GAS coverage; MRSA-focused.

D — Review: Overly broad/reserved for resistant MRSA or intolerance.

E — Review: Poor streptococcal coverage; not indicated. 

Pediatric Emergency Medicine Practice Question 2 - Abscess on ultrasound 

A 6-year-old has a tender arm lesion with fluctuance; ultrasound shows a 1.5 cm fluid collection. Afebrile, well-appearing. Best next step?

  • A. Incision and drainage
  • B. Oral penicillin V only
  • C. IV vancomycin immediately
  • D. Topical mupirocin only
  • E. Oral amoxicillin only

Answer and Remediation

A — Correct response!: Purulent collection requires drainage; antibiotics depend on severity/risk (IDSA 2014).

B — Review: Drainage is primary therapy when abscess present.

C — Review: IV therapy not indicated for uncomplicated small abscess in a well child.

D — Review: Inadequate for abscess.

E — Review: Inadequate; misses MRSA consideration if antibiotics used. 

 

Pediatric Emergency Medicine Practice Question 3 - Nonpurulent cellulitis with MRSA risk 

A 14-year-old with nonpurulent cellulitis and a history of MRSA infection last year. No abscess on ultrasound. Appropriate empiric oral regimen?

  • A. Penicillin V
  • B. Amoxicillin alone
  • C. Cephalexin plus trimethoprim/sulfamethoxazole
  • D. Azithromycin
  • E. Metronidazole

Answer and Remediation

A — Review: No MRSA coverage.

B — Review: No MRSA coverage.

C — Correct response!: Add MRSA-active agent when MRSA risk factors exist; keep beta-lactam for streptococci (IDSA 2014).

D — Review: Macrolide resistance among GAS; not preferred.

E — Review: Anaerobe coverage; irrelevant. 

Pediatric Emergency Medicine Practice Question 4 - Why TMP-SMX fails  

A clinician chooses TMP-SMX monotherapy for a child with classic nonpurulent cellulitis and no abscess. The main problem is:

  • A. It has excessive anaerobic coverage
  • B. It has unreliable streptococcal coverage
  • C. It is contraindicated in all children
  • D. It is ineffective against MRSA
  • E. It cannot be given orally
Answer and Remediation

A — Review: Not the issue.

B — Correct response!: Nonpurulent cellulitis is usually streptococcal; TMP-SMX does not reliably cover GAS (IDSA 2014).

C — Review: Not true.

D — Review: TMP-SMX is active vs many MRSA strains.

E — Review: It is available orally. 

Pediatric Emergency Medicine Practice Question 5 - Erysipelas vs cellulitis 

A 7-year-old has a sharply demarcated, raised, tender erythematous plaque on the cheek with fever; no abscess. Most likely pathogen and best first-line class?

  • A. MSSA; tetracycline
  • B. Group A Streptococcus; penicillin-class beta-lactam
  • C. Pseudomonas; fluoroquinolone
  • D. Candida; azole
  • E. MRSA; TMP-SMX monotherapy
Answer and Remediation

A — Review: Erysipelas is classically streptococcal.

B — Correct response!: Erysipelas is most often GAS; treat with penicillin-class agents (AAP Red Book; IDSA 2014).

C — Review: Not typical.

D — Review: Not typical.

E — Review: MRSA not the classic cause; TMP-SMX monotherapy misses GAS. 

 

Mini Case Discussion Prompt

How would your empiric antibiotic choice change (and why) if this same child had (1) a drainable abscess on ultrasound, (2) prior MRSA colonization, or (3) a facial sharply demarcated erysipelas-like rash?

 

Mini-FAQ

Q1: What does “cobblestoning” on ultrasound mean for boards?
A: It indicates subcutaneous edema consistent with cellulitis and helps rule in cellulitis while looking for an abscess; ABP/PEM-style questions use it to push you away from unnecessary I&D when no collection is seen.

Q2: When should you add MRSA coverage for cellulitis?
A: When there is purulence/abscess or MRSA risk factors (prior MRSA infection/colonization, close contacts, high-prevalence settings, etc.), consistent with IDSA Skin/Soft Tissue Infection guidance (2014).

Q3: Why aren’t doxycycline or TMP-SMX good monotherapy for nonpurulent cellulitis?
A: Because streptococci are the key pathogens and both have unreliable Group A Strep activity; boards test that you must not sacrifice GAS coverage.

Q4: What first-line outpatient drug do many pathways prefer if available?
A: Cephalexin (or similar first-generation cephalosporin) is commonly preferred because it covers streptococci and MSSA—this is a frequent exam-prep default even though it is not listed in this item.


Find this and other Pediatric Emergency Medicine exam prep questions in Med-Challenger Pediatric Emergency Medicine 3rd Edition Exam Review with CME

Try for free and save. Ace your exams and meet your CME/MOC requirements.

Pediatric Emergency Medicine Exam Review


No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.

For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners. 

 
Never miss a thing. Subscribe to our blog and save!
 
SUBSCRIBE Medical Education Blog & Newsletter

Similar posts

Stay informed.

Subscribe to our Medical Education Blog 

Stay informed of new medical education content, certification requirements and deadlines, case-based CME quizzes, and special offers.